2013 ASCO Annual Meeting
May 15th, 2013
Genentech to report new advances at the American Society of Clinical Oncology Annual Meeting
Genentech will present important new data from studies of several cancer medicines at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) from May 31-June 4, 2013, in Chicago.
This page is intended to be a media resource for Genentech developments at ASCO. It will be updated frequently throughout the meeting.
Related news releases
Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO
Data on investigational Genentech medicine shows significant PFS improvement in people with CLL
Update on Study Results of Medicine in People with Newly Diagnosed Glioblastoma
Genentech's Medicine Improved Survival in Women with Advanced Cervical Cancer
About the Lung Cancer Project
Data from The Lung Cancer Project, a study exploring if people, including doctors, have inherent biases against lung cancer, is being presented at this year’s meeting.
Learn more
Fact Sheets
Visit our ASCO newsroom to read more about this year's key topics at ASCO.